Cargando…
Vesicular Stomatitis Virus-Vectored Multi-Antigen Tuberculosis Vaccine Limits Bacterial Proliferation in Mice following a Single Intranasal Dose
Tuberculosis (TB) remains a serious health problem worldwide, and an urgent need exists to improve or replace the available vaccine, Mycobacterium bovis bacillus Calmette-Guérin (BCG). Most vaccination protocols adapt two or three doses to induce long-term lasting immunity. Our previous study showed...
Autores principales: | Zhang, Ming, Dong, Chunsheng, Xiong, Sidong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5293745/ https://www.ncbi.nlm.nih.gov/pubmed/28224119 http://dx.doi.org/10.3389/fcimb.2017.00034 |
Ejemplares similares
-
Immunohistochemical and behaviour pharmacological analysis of rats inoculated intranasally with vesicular stomatitis virus
por: Andersson, Tommy, et al.
Publicado: (1993) -
A vesicular stomatitis virus-based mucosal vaccine promotes dendritic cell maturation and elicits preferable immune response against coxsackievirus B3 induced viral myocarditis
por: Wu, Fei, et al.
Publicado: (2014) -
High dose of vesicular stomatitis virus-vectored Ebola virus vaccine causes vesicular disease in swine without horizontal transmission
por: Morozov, Igor, et al.
Publicado: (2021) -
Vesicular Stomatitis Virus Transmission: A Comparison of Incriminated Vectors
por: Rozo-Lopez, Paula, et al.
Publicado: (2018) -
Recombinant vesicular stomatitis virus as an HIV-1 vaccine vector
por: Clarke, David K., et al.
Publicado: (2006)